We are live on
!
Find out more
PCM
Perkins Capital Management Portfolio holdings
AUM
$133M
1-Year Est. Return
127.86%
This Fund
S&P 500
This Quarter
Est. Return
+17.18%
1 Year Est. Return
+127.86%
3 Year Est. Return
+303.11%
5 Year Est. Return
+333.48%
10 Year Est. Return
–
AUM
$109M
AUM Growth
–
Cap. Flow
+$107M
Cap. Flow
% of AUM
98.65%
Top 10 Holdings %
Top 10 Hldgs %
40.45%
Holding
93
New
93
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NeoGenomics
NEO
|
+$7.42M |
| 2 |
Vericel Corp
VCEL
|
+$4.58M |
| 3 |
Veracyte
VCYT
|
+$4.15M |
| 4 |
Idexx Laboratories
IDXX
|
+$4.14M |
| 5 |
CareDx
CDNA
|
+$4.04M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 65.3% |
| 2 | Technology | 12.81% |
| 3 | Communication Services | 6.99% |
| 4 | Industrials | 4.39% |
| 5 | Consumer Staples | 4.09% |
Similar funds
PWP
BF
HWMG
FTEA
WT
BAM
WLG
PA
Perkins Capital Management's Q3 2020 Portfolio in Review
Q3 2020 is the first quarter with a 13F filing on record for Perkins Capital Management, which disclosed 93 positions worth $109M. Its ten largest holdings account for 40% of the portfolio.
Its largest position is NeoGenomics: 199,525 shares worth $7.36M.
By sector, the portfolio is most concentrated in Healthcare at 65% of assets, followed by Technology and Communication Services.
- Perkins Capital Management's largest Q3 2020 buy was NeoGenomics: 199,525 shares worth $7.36M.
- Perkins Capital Management's ten largest holdings make up 40% of its $109M portfolio in Q3 2020.
- Perkins Capital Management disclosed 93 positions in Q3 2020, its first 13F filing on record.
Based on Perkins Capital Management's 13F filing for Q3 2020, filed 28 Oct 2020.